Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Bernstein

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Ophthalmology|February 14, 2004
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter studyPaula Bernstein
Reviews in Cardiovascular Medicine|March 9, 2013
Coronary artery disease. Tetrahydrobiopterin: a new piece of the postmenopausal cardiovascular puzzlePaula Bernstein
Reviews in Cardiovascular Medicine|November 4, 2010
Progesterone, progestins, and the heartPaula Bernstein, Gerald Pohost
Reviews in Cardiovascular Medicine|March 11, 2011
Progesterone, progestins, and the heartPaula Bernstein, Gerald Pohost
American Journal of Ophthalmology|June 20, 2008
A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprostSteven T Simmons, Paula Bernstein, David A Hollander
Survey of Ophthalmology|March 16, 2004
A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressureNeil Choplin, Paula Bernstein, Amy L Batoosingh, et al.
American Journal of Ophthalmology|November 30, 2010
Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapyGeorge L Spaeth, Paula Bernstein, Joseph Caprioli, et al.
Ophthalmology|December 4, 2003
A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertensionAnne L Coleman, Fabian Lerner, Paula Bernstein, et al.
Journal of Ophthalmology|October 24, 2017
A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular PressureCurt Hartleben, Juan Camilo Parra, Amy Batoosingh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 11, 2015
Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patientsM Francesca Cordeiro, Ivan Goldberg, Rhett Schiffman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Ophthalmology|February 14, 2004
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter studyPaula Bernstein
Reviews in Cardiovascular Medicine|March 9, 2013
Coronary artery disease. Tetrahydrobiopterin: a new piece of the postmenopausal cardiovascular puzzlePaula Bernstein
Reviews in Cardiovascular Medicine|November 4, 2010
Progesterone, progestins, and the heartPaula Bernstein, Gerald Pohost
Reviews in Cardiovascular Medicine|March 11, 2011
Progesterone, progestins, and the heartPaula Bernstein, Gerald Pohost
American Journal of Ophthalmology|June 20, 2008
A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprostSteven T Simmons, Paula Bernstein, David A Hollander
Survey of Ophthalmology|March 16, 2004
A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressureNeil Choplin, Paula Bernstein, Amy L Batoosingh, et al.
American Journal of Ophthalmology|November 30, 2010
Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapyGeorge L Spaeth, Paula Bernstein, Joseph Caprioli, et al.
Ophthalmology|December 4, 2003
A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertensionAnne L Coleman, Fabian Lerner, Paula Bernstein, et al.
Journal of Ophthalmology|October 24, 2017
A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular PressureCurt Hartleben, Juan Camilo Parra, Amy Batoosingh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 11, 2015
Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patientsM Francesca Cordeiro, Ivan Goldberg, Rhett Schiffman, et al.
Pageof 2